Arca
Skip to content
Tools
Tools

LIAISON® XL MUREX HBsAg Qual, LIAISON® MUREX Control HBsAg, and LIAISON® XL MUREX HBsAg Confirmatory Test

Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen). PMA P190017, from DiaSorin, Inc. (Stillwater, MN). Product code LOM, class 3.

As of Nov 22, 2026, P190017 is an FDA PMA held by DiaSorin, Inc., approved on Aug 29, 2020 after 428 days, with no recalls tied to it in FDA's recall database.

  • Review time: 428 days
  • Supplements: 25
  • Recalls: 0
  • Cited as a predicate by: 1 device

What FDA approved

FDA's approval order statement

Approval for the LIAISON® XL MUREX HBsAg Qual, LIAISON® MUREX Control HBsAg, and LIAISON® XL MUREX HBsAg Confirmatory Test. The LIAISON® XL MUREX HBsAg Qual assay is an in vitro chemiluminescent immunoassay for the qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric (2 to 21 years) serum and plasma (lithium and sodium heparin, sodium citrate and potassium EDTA) including separator tubes, on the LIAISON® XL Analyzer. Assay results in conjunction with other hepatitis B virus (HBV) serological and clinical information, may be used as an aid in the diagnosis of HBV infection in patients with symptoms of hepatitis or who may be at risk for HBV infection. The assay may also be used to screen for HBV infection in pregnant women to identify neonates who are at risk for acquiring hepatitis B during the perinatal period.The LIAISON® XL MUREX Control HBsAg…

Pivotal study

The main clinical evidence FDA relied on, as its Summary of Safety and Effectiveness describes it
Design
Prospective and retrospective multi-site clinical agreement study vs. FDA-approved reference HBsAg assay
Enrolled
3,082
Where
Russia, Colombia, Cameroon, Ghana, Nigeria, US
Primary endpoint
Positive percent agreement (PPA) and negative percent agreement (NPA) vs. FDA-approved reference HBsAg assay
Result
PPA 98.3% (95% CI 96.0%-99.3%); NPA 99.8% (95% CI 99.5%-99.9%)

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Supplements

25 supplements to this PMA; the 15 newest
Oct 10, 2025S026Change Design/Components/Specifications/MaterialReal-Time Process
Aug 28, 2025S028Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Aug 21, 2025S027Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Apr 25, 2025S023Change Design/Components/Specifications/MaterialReal-Time Process
Apr 16, 2025S018Change Design/Components/Specifications/MaterialNormal 180 Day Track
Apr 10, 2025S025Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Feb 25, 2025S024Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jan 6, 2025S022Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Dec 19, 2024S021Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jul 12, 2024S020Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Jun 4, 2024S019Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Nov 8, 2023S017Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Oct 5, 2023S016Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Sep 28, 2023S015Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice
Aug 22, 2023S014Process Change - Manufacturer/Sterilizer/Packager/Supplier30-Day Notice

Other LOM clearances

The newest 510(k)s for the same product code; see every LOM device

Record

Type
Original PMA
Received
Jun 28, 2019
Review panel
Microbiology
Regulation
21 CFR 866.3172

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.